Detalles de la búsqueda
1.
Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicenter, Randomized, Controlled Clinical Trial.
Am J Respir Crit Care Med;
208(3): 256-269, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37154608
2.
Repair of acute respiratory distress syndrome by stromal cell administration (REALIST): a structured study protocol for an open-label dose-escalation phase 1 trial followed by a randomised, triple-blind, allocation concealed, placebo-controlled phase 2 trial.
Trials;
23(1): 401, 2022 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35562778
3.
Repair of acute respiratory distress syndrome by stromal cell administration (REALIST) trial: A phase 1 trial.
EClinicalMedicine;
41: 101167, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34746723
4.
Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
Trials;
21(1): 462, 2020 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32493473
Resultados
1 -
4
de 4
1
Próxima >
>>